Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 31;19(5):e0303446.
doi: 10.1371/journal.pone.0303446. eCollection 2024.

Polygenic risk score for acute rejection based on donor-recipient non-HLA genotype mismatch

Affiliations

Polygenic risk score for acute rejection based on donor-recipient non-HLA genotype mismatch

Rui Cao et al. PLoS One. .

Abstract

Background: Acute rejection (AR) after kidney transplantation is an important allograft complication. To reduce the risk of post-transplant AR, determination of kidney transplant donor-recipient mismatching focuses on blood type and human leukocyte antigens (HLA), while it remains unclear whether non-HLA genetic mismatching is related to post-transplant complications.

Methods: We carried out a genome-wide scan (HLA and non-HLA regions) on AR with a large kidney transplant cohort of 784 living donor-recipient pairs of European ancestry. An AR polygenic risk score (PRS) was constructed with the non-HLA single nucleotide polymorphisms (SNPs) filtered by independence (r2 < 0.2) and P-value (< 1×10-3) criteria. The PRS was validated in an independent cohort of 352 living donor-recipient pairs.

Results: By the genome-wide scan, we identified one significant SNP rs6749137 with HR = 2.49 and P-value = 2.15×10-8. 1,307 non-HLA PRS SNPs passed the clumping plus thresholding and the PRS exhibited significant association with the AR in the validation cohort (HR = 1.54, 95% CI = (1.07, 2.22), p = 0.019). Further pathway analysis attributed the PRS genes into 13 categories, and the over-representation test identified 42 significant biological processes, the most significant of which is the cell morphogenesis (GO:0000902), with 4.08 fold of the percentage from homo species reference and FDR-adjusted P-value = 8.6×10-4.

Conclusions: Our results show the importance of donor-recipient mismatching in non-HLA regions. Additional work will be needed to understand the role of SNPs included in the PRS and to further improve donor-recipient genetic matching algorithms. Trial registry: Deterioration of Kidney Allograft Function Genomics (NCT00270712) and Genomics of Kidney Transplantation (NCT01714440) are registered on ClinicalTrials.gov.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Manhattan plot of the genome-wide scan in the DeKAF Genomics cohort.
Fig 2
Fig 2. The distribution of donor-recipient mismatching PRS scores in the DeKAF Genomics and GEN-03 cohorts.
Fig 3
Fig 3. Functional classification of the genes involved in donor-recipient mismatching PRS.
Fig 4
Fig 4. Results of over-representation test for the PRS genes.

Similar articles

Cited by

References

    1. Sijpkens YWJ, Doxiadis IIN, Mallat MJK, Fijter JW, Brujin JA, Claas FHJ, et al.. Early versus late acute rejection episodes in renal transplantation. Transplantation. 2003;75(2):204–208. doi: 10.1097/01.TP.0000041722.34000.21 - DOI - PubMed
    1. Lebranchu Y, Baan C, Biancone L, Legendre C, Morales JM, Narsens M, et al.. Pretransplant identification of acute rejection risk following kidney transplantation. Transpl Int. 2014;27(2):129–138. doi: 10.1111/tri.12205 - DOI - PubMed
    1. Opelz G, Wujciak T, Döhler B, Scherer S, Mytilineos J. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev Immunogenet. 1999;1(3):334–342. - PubMed
    1. Almoguera B, Shaked A, Keating BJ. Transplantation Genetics: Current Status and Prospects. Am J Transplant. 2014;14(4):764–778. doi: 10.1111/ajt.12653 - DOI - PubMed
    1. Loos RJF. 15 years of genome-wide association studies and no signs of slowing down. Nat Commun. 2020;11(1):5900. doi: 10.1038/s41467-020-19653-5 - DOI - PMC - PubMed

Associated data